RxDoctor Payments Data

Barry Callahan, MD

Hand Surgery · Tuscaloosa, ALNPI 1013989995

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 9 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 6 manufacturers reported payments, led by Smith+Nephew at 28.4% of the total. Reporting peaked in 2024 at $252 and has fallen 84.2% since, to $40 in 2025. That places this record below the midpoint for hand surgery clinicians in AL, where the typical reported total is $2,588.

$529in general payments, 2019–2025

Across 9 payments — averaging $58.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Smith+Nephew$150
  • Acumed LLC$148
  • Ossur Americas, Inc.$117
  • Boston Scientific$54
  • Endo Pharmaceuticals Inc.$35
  • Johnson & Johnson$25

What the payments were for

  • Food & beverage$529100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Smith+Nephew2$150
Acumed LLC1$148
Ossur Americas, Inc.1$117
Boston Scientific2$54
Endo Pharmaceuticals Inc.2$35
Johnson & Johnson1$25

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$529 in reported general payments places this provider in the 20th percentile of 29 hand surgery providers in Alabama.

See all hand surgery providers in Alabama

Medicare billing

Part B allowed, 2024
$343,993
Medicare patients
416
Services billed
4,554

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
XiaflexCollagenase Clostridium Hist.17$192,469
Cephalexin135$605
Ibuprofen167$595
Meloxicam176$555
Oxycodone Hcl142$422
Clindamycin Hcl35$192
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen20$92
Tramadol Hcl43$89
Prednisone23$59

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Endo Pharmaceuticals Inc.Xiaflex$35$192,46917 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 20th percentile of 29 hand surgery providers in Alabama.

Other hand surgery in Tuscaloosa

See the full list for Alabama

Where these figures come from

Is this you, or does something look wrong? →